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Radiotherapy of head and neck squamous cell carcinoma can lead to long‑term complications like 
osteoradionecrosis, resulting in severe impairment of the jawbone. Current standard procedures 
require a 6‑month wait after irradiation before dental reconstruction can begin. A comprehensive 
characterization of the irradiation‑induced molecular and functional changes in bone cells could 
allow the development of novel strategies for an earlier successful dental reconstruction in patients 
treated by radiotherapy. The impact of ionizing radiation on the bone‑forming alveolar osteoblasts 
remains however elusive, as previous studies have relied on animal‑based models and fetal or animal‑
derived cell lines. This study presents the first in vitro data obtained from primary human alveolar 
osteoblasts. Primary human alveolar osteoblasts were isolated from healthy donors and expanded. 
After X‑ray irradiation with 2, 6 and 10 Gy, cells were cultivated under osteogenic conditions and 
analyzed regarding their proliferation, mineralization, and expression of marker genes and proteins. 
Proliferation of osteoblasts decreased in a dose‑dependent manner. While cells recovered from 
irradiation with 2 Gy, application of 6 and 10 Gy doses not only led to a permanent impairment of 
proliferation, but also resulted in altered cell morphology and a disturbed structure of the extracellular 
matrix as demonstrated by immunostaining of collagen I and fibronectin. Following irradiation with 
any of the examined doses, a decrease of marker gene expression levels was observed for most of 
the investigated genes, revealing interindividual differences. Primary human alveolar osteoblasts 
presented a considerably changed phenotype after irradiation, depending on the dose administered. 
Mechanisms for these findings need to be further investigated. This could facilitate improved patient 
care by re‑evaluating current standard procedures and investigating faster and safer reconstruction 
concepts, thus improving quality of life and social integrity.
Multi-disciplinary treatment with curative (chemo)radiotherapy (RT) is recommended in patients with locally 
advanced head and neck squamous cell carcinoma (HNSCC)1. Dental assessment and stabilizing oral health 
before RT are crucial as dental extraction or invasive interventions following RT might be risk factors for osteo-
radionecrosis of the jaw, a serious late side effect after RT  treatment2–4. The conservative course of action for 
dental rehabilitation is to place enosseal implants 6 months after chemotherapy and radiation treatment at the 
earliest. This prolongs deficits in oral health and social integrity, which play an important role in the quality of 
life of patients with  HNSCC5,6. Profound knowledge of the effects of radiation on human alveolar bone cells is 
still lacking, though it is decisive to plan dental implant concepts after the therapy. Neckel et al.7 showed that 
the radiation dose to the specific area of the implants can be seen as a relevant risk factor for peri-implant tissue 
health and therefore long-term survival.
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The in vivo situation in the irradiated jaw is highly complex due to the interplay of the various cell types 
present in the alveolar bone, the surrounding soft tissue and the microbiome. Possible mechanisms of radiation-
induced late damages on mandibular bone are hypovascularization, and a reduction of osteoblast numbers, osteo-
blastic activity and bone  regeneration8–11. Osteoblasts have been repeatedly reported to be a major contributor to 
the decrease in bone density after  irradiation12–15. Previous in vitro studies have relied on osteoblastic murine cell 
lines like MC3T3-E1 or human fetal cell lines from skeletal  bones16–21. These models can only partially mimic the 
in vivo situation due to interspecies differences and the fact that alveolar osteoblasts behave differently than those 
derived from long bones, for example regarding their proliferation, mineralization and angiogenic  properties22,23.
This is the first study employing primary human alveolar osteoblasts to investigate the impact of irradiation 
on this cell type, which is essential for the regeneration of bone. Human alveolar osteoblasts were irradiated with 
2, 6, and 10 Gy and compared to non-irradiated controls regarding their proliferation, morphology, mineraliza-
tion, and expression of marker genes and proteins.
Results
Impact of irradiation on the proliferation. Irradiation of primary jawbone-derived human osteoblasts 
(JHOBs) decreased but did not completely abolish the proliferation over the course of the experiment, as indi-
cated by the proliferation index (PI) (Fig. 1a). In general, a higher radiation dose resulted in a flatter slope of 
the curve  (P0 Gy vs. 2/6/10 Gy < 0.0001,  P2 Gy vs. 6/10 Gy < 0.0001,  P6 Gy vs. 10 Gy = 0.0011, Supplementary Table S1). Looking 
at individual donors, all three JHOB cultures showed a dose-dependent decrease in proliferation after irradia-
tion, with the cell culture from donor 3 presenting overall a significantly lower PI (Supplementary Fig. S1a–c; 
 Pdonor 1 vs. 3 = 0.0011,  Pdonor 2 vs. 3 < 0.0001, Supplementary Table S2). Proliferation of cells irradiated with 2 Gy was 
lower compared to untreated cells, although differences were small and only significant for donor 3, but not 
donor 1 and 2  (Pdonor 1 = 0.9519,  Pdonor 2 = 0.7793,  Pdonor 3 = 0.0219). In contrast, treatment with 6 and 10 Gy signifi-
cantly inhibited the proliferative activity compared to the non-irradiated controls for all donors (Supplementary 
Table S3). A significant difference of the effect of irradiation on the JHOBs was determined between the irra-
diation conditions for all combinations, except for donor 1, 2 and 6 Gy (P = 0.077), and donor 2, 6 and 10 Gy 
(P = 0.2589).
Figure 1.  Impact of irradiation on the proliferation of JHOBs. (a) Proliferation is inversely proportional to 
the MFI of the CellTrace Violet dye. JHOBs were stained with CellTrace Violet, seeded, and irradiated the next 
day. Sampling was performed every day and cells were analyzed using flow cytometry. Proliferation index is 
calculated as the inverse normalized MFI of CellTrace. Data are presented as mean ± s.d. n = 3 donors, where 
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Monolayer cultures of JHOBs from donor 3 were less confluent after 7 days of cultivation compared to the 
other donors (Fig. 1b–d, top lanes). JHOBs irradiated with 6 or 10 Gy were not able to form a confluent mon-
olayer after 28 days of cultivation, while 2 Gy conditions were qualitatively not discernible to 0 Gy on day 28 
(Fig. 1b–d, bottom lanes).
Impact of irradiation on the mineralization. The impact of different irradiation doses on the miner-
alization varied between the donors. For donor 1, strong mineralization was only observed for cells treated with 
6 Gy (Fig. 2a,b), whereas low mineralization was observed for the other conditions. Donors 2 and 3 displayed 
similar patterns, where lower mineralization correlated with higher radiation doses (Fig. 2c,e). However, miner-
alization levels were overall very low for donor 2 as clearly recognizable in the staining images (Fig. 2d,f).
Impact of irradiation on the protein expression. Monolayers were stained to qualitatively assess 
marker gene expression on the protein level. Fibronectin expression was found to be altered following irra-
diation (Fig. 3). For all donors, non-irradiated and cells irradiated with 2 Gy displayed a dense, well-organized 
network. In contrast, the staining pattern for fibronectin appeared different in cultures treated with 6 and 10 Gy, 
coinciding with the presence of enlarged nuclei. Staining for vimentin revealed an altered morphology with 
irregular shapes and expanded cell bodies for cells treated with 6 and 10 Gy (Fig. 4). Expression of RUNX2 
Figure 2.  Mineralization of irradiated JHOBs. JHOBs were treated with different radiation doses and the level 
of mineralization was quantitatively (a, c, e) and qualitatively (b, d, f) assessed after 28 days of cultivation by 
Alizarin Red S staining. n = 3 biological replicates for each donor.
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(Fig. 4), ALPL, osteopontin (Fig. 5) and osteonectin (Supplementary Fig. S2) was demonstrated for all condi-
tions, with no discernible changes of the staining patterns besides the enlargement of the cells. Collagen I was 
found to be expressed in the cytoplasm on day 0, while extensive staining of the well was found for 0 and 2 Gy 
conditions (except for donor 2). A less homogenous deposition of collagen I was visible in 6 and 10 Gy condi-
tions (all donors), and also in the 2 Gy condition of donor 2 (Fig. 6). No unspecific staining of secondary anti-
bodies was detected (Supplementary Fig. S3).
Figure 3.  Immunostaining of irradiated JHOBs for fibronectin. Cells were irradiated with 2, 6 and 10 Gy or 
sham, and stained for expression of fibronectin (red) after 28 days of cultivation in osteogenic medium. Non-
treated cells on day 0 were used as a control. Nuclei were counterstained with DAPI (yellow).
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Impact of irradiation on the marker gene expression. Expression of ALPL was upregulated for non-
irradiated controls (P < 0.0001) and upon irradiation with 2 Gy (P = 0.0002) (Fig. 7). After 28 days of cultivation, 
a significant downregulation upon irradiation with 6 and 10 Gy was detected compared to a 2 Gy dose and non-
Figure 4.  Immunostaining of irradiated JHOBs for RUNX2 and vimentin. Cells were irradiated with 2, 6 and 
10 Gy or sham, and stained for expression of RUNX2 (cyan) and vimentin (red) after 28 days of cultivation in 
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irradiated controls (Supplementary Table S4). A significant increase of SPARC expression was observed over the 
course of the experiment in non-irradiated cultures (P < 0.0001). Here, irradiation resulted in a decrease on day 
Figure 5.  Immunostaining of irradiated JHOBs for ALPL and osteopontin. Cells were irradiated with 2, 6 and 
10 Gy or sham, and stained for expression of ALPL (cyan) and osteopontin (red) after 28 days of cultivation in 
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7 which was significant for an irradiation with 10 Gy (P = 0.0375). On day 28, expression levels were significantly 
lowered for all doses (P < 0.0001).
Expression levels of COL1A1 and RUNX2 appeared stable for non-irradiated cells over the course of the 
experiment. Upon irradiation, a tendency for a dose-dependent reduction of the expression was observable. 
Figure 6.  Immunostaining of irradiated JHOBs for collagen I. Cells were irradiated with 2, 6 and 10 Gy or 
sham, and stained for expression of collagen I (cyan) after 28 days of cultivation in osteogenic medium. Non-
treated cells on day 0 were used as a control. Nuclei were counterstained with DAPI (yellow).
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Expression of SPP1 in non-irradiated cells decreased from day 0 to day 7, followed by an increase to day 28. 
Figure 7.  Marker gene expression of irradiated JHOBs. Relative gene expression of the osteoblast differentiation 
markers ALPL, COL1A1, RUNX2, SPARC, and SPP1 were cultivated in osteogenic medium and analyzed on 
days 0, 7 and 28. Expression was normalized to UBE2D2 expression. * = P < 0.05. ** = P < 0.01. *** = P < 0.001. 
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Following irradiation, the expression levels showed a tendency to slight elevation on day 7, which was inversed 
on day 28.
Discussion
Previous studies on the effects of irradiation on osteoblasts have shown contradicting  results21,24–26. This can 
be partly explained by the utilization of multiple cell lines, which resemble varying differentiation  states27. In 
contrast, this is the first study investigating primary human osteoblasts obtained from the jawbone. Here, results 
from previous studies were partially confirmed, as detailed below. In this context, interindividual heterogeneities 
in the response of JHOBs to the irradiation were observed. This indicates the feasibility to differentiate between 
radiation-insensitive and radiation-sensitive patients, which could enable personalized treatment concepts for 
dental reconstruction following radiotherapy.
A dose-dependent decrease of the proliferation capacity was demonstrated (Fig. 1), as has been reported 
 before17,19,25,28. One possible explanation is a reversible or permanent shift in the cell cycle  distribution16,19,21,26. 
Deeper insights into molecular mechanisms are desirable but were beyond the scope of this study. Additionally, 
a decrease in proliferation has been associated with the induction of differentiation as well as cell  destruction17. 
The present data suggest that differentiation of alveolar osteoblasts was not enhanced by irradiation as shown by 
mineralization and gene expression (Figs. 2 and 7), contradicting previous studies using murine cell  lines17,21,25.
Several authors have reported a certain threshold below which a few aspects of cell function were 
 recovered19,21,26. This was to some extent confirmed in the present study. For instance, confluent monolayers 
were observed after 28 days of cultivation for cells treated with 2 Gy and controls, but not for 6 and 10 Gy 
(Fig. 1b–d). Immunostaining demonstrated analogous results since staining patterns for 2 Gy and controls were 
not distinguishable for most of the markers (Figs. 3, 4, 5). However, interindividual differences were observed 
as 2 Gy-irradiated cells of donor 2 displayed an altered staining pattern of collagen I, whereas those of donor 
1 and 3 did not (Fig. 6). This again underlines the need for a higher number of donors in follow-up studies to 
allow for more universal conclusions.
Irradiation with 6 and 10 Gy resulted in an altered cell morphology, independent from the donors (Figs. 4, 5, 
Supplementary Fig. S2). The number of cells was decreased, while cell bodies and nuclei were enlarged, in accord-
ance with observations made by Huang et al.18. Immunostaining revealed that the organization of fibronectin, 
one of the most abundant extracellular matrix (ECM) proteins secreted by the  cells29, was disrupted, leading 
to impairment of the ECM (Fig. 3). This can also impact differentiation of osteoblasts, as this process requires 
interaction with fibronectin via integrin  receptors30, as well as formation of new  bone29. Analogously, irradiation 
with 6 and 10 Gy affected the overall expression of collagen I (Fig. 6), which is the main organic component 
of the bone  matrix31, changing from a diffused to a more condensed staining pattern. High irradiation doses 
might therefore impair the formation of the ECM and alter the bone structure, as has been reported for  ORN32.
As this is the first pilot study investigating irradiation effects on primary human alveolar osteoblasts, only 
three donors were examined. As expected based on the observation of a donor-specific behavior of alveolar 
osteoblasts in previous in vitro and in vivo  studies22,33–35, differences between donors were observed regarding the 
impact of irradiation, particularly concerning the mineralization capacity and gene expression. To compensate 
for interindividual differences and therefore enable more universal conclusions, the number of donors should be 
increased. Another highly interesting possibility is the investigation of gender-specific differences, as previous 
studies have reported an impact of the gender on clinical aspects and cell  physiology7,23.
The existence of heterogenous populations in the ex vivo cultures is another potential explanation for varying 
results. In general, highly proliferative cells are being more affected by irradiation. For donor 1, administration 
of 6 and 10 Gy could have led to survival of less proliferative and therefore more differentiated osteogenic cells, 
resulting in a distinct red staining of the matrix (Fig. 2b), compared to 0 and 2 Gy. In contrast, JHOBs isolated 
from donor 3 presented an overall more differentiated phenotype, as shown by their lower proliferation (Sup-
plementary Fig. S1c, Supplementary Table S1) and stronger mineralization of non-irradiated cells (Fig. 2e) 
compared to the other donors. Advanced methods like single cell sequencing and analysis of DNA methylation 
patterns can help to unravel this.
Differing results between donors can also arise from the origin of the JHOBs, since the bone specimen used 
for this study were obtained both from mandibular (donor 1) and maxillary (donors 2 and 3) jawbone. Although 
they share the same developmental origin, their physiologies differ, for example regarding the ratio of cortical 
and cancellous bone, vascular density, and the size of medullary  cavities36–38. This could for example explain the 
dissimilar behavior of cells regarding their mineralization. Here, donor 3 presented a dose-dependent impair-
ment of mineralization, whereas mineralization was strongly increased after irradiation with 6 Gy for donor 1. A 
separate evaluation of mandible- and maxilla-derived JHOBs in further studies with a higher number of donors 
per group could elucidate this hypothesis and shed light on whether perceived clinical differences between the 
upper and lower jaw concerning osteoradionecrosis and implant success really exist.
The transferability of in vitro results to the real multimodal treatment situation for a head and neck cancer 
patient in vivo is of particular interest. An important factor that needs to be considered is the way of radiotherapy 
administration. Several authors have pointed out the impact of single dose vs. fractionated radiation, and of the 
irradiation time  point16,17,24,25. Furthermore, frequently used photon-based irradiation techniques, proton therapy 
or a combination of both can be used in head and neck cancer  treatment39.
In general, the correlation of the in vitro vs. the in vivo dose must be  considered17. Although this study gives 
first insights into the radiobiology of human alveolar osteoblasts, the transferability is somehow limited as it is 
based on a two-dimensional cultivation considering only the investigated cell type. The employment of three-
dimensional models like our recently published bioprinted human jawbone model might provide more reliable 
results than those obtained from conventional 2D  culture40. Furthermore, the mutual impact of other cell types 
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present in the irradiated bone and soft tissue, including osteoclasts and osteocytes, has to be taken into account 
to simulate the complex in vivo situation.
Characterising in vitro changes of human alveolar osteoblasts after RT is certainly one step in providing 
additional information on the mechanism of RT damage and pathogenesis of ORN of the jaw. Furthermore, 
the different theories by Marx, Delanian and Lefaix propose poor vascularisation as a common feature in the 
pathogenesis of  ORN41,42. Vascularity has been studied most frequently in animal  models43–46, and more recently 
quantitative research in human mandibular bone found a decrease in the number and density of vessels with 
higher doses affecting mainly the smaller  vessels47. Employing co-culture models featuring both endothelial 
cells and osteoblasts for irradiation studies could to some extent recapitulate this complex interplay and provide 
further insights into the role of the (micro)vascular  system40,48,49. Here, JHOBs were investigated detached from 
other cell types, generating the first data on the impact of irradiation.
Conclusions
Taken together, this study provides first insights into the dose-dependent effect of irradiation on primary human 
osteoblasts obtained from the alveolar bone. Further investigations on the underlying molecular mechanisms 
might reveal potential targets for the prevention, or risk factors for the development of late damages like oste-
onecrosis. This can eventually contribute to a safer and more predictable patient-specific implant therapy based 
on the irradiation dose administered for HNSCC therapy, and therefore to an improvement in patient care by 
refining the timing of implant-support prosthetic rehabilitation.
Methods
Cell isolation and culture. Primary jawbone-derived human osteoblasts (JHOBs) were isolated following 
slightly modified  protocols22,50. Small bone pieces (approximately 8  mm3) of human mandibular (donor 1) or 
maxillary (donors 2 and 3) jawbone were obtained from healthy donors between 72 and 79 years old during 
surgery (Informed consent of all participating subjects was obtained, and all methods were performed in accord-
ance with the relevant guidelines and regulations, as approved by Charité’s Ethics Committee, EA4/064/18). 
Samples were stored at 4  °C in growth medium (high-glucose DMEM supplemented with 10% fetal bovine 
serum (FBS), 100 IU  mL−1 penicillin, 100 µg  mL−1 streptomycin and 2 mM GlutaMAX (Gibco, Thermo Fisher 
Scientific, Waltham, USA)) until isolation. After removing remaining soft tissue using a scalpel and thoroughly 
rinsing with phosphate buffered saline (PBS), bone pieces were incubated in Betaisodona iodide solution (Mun-
dipharma, Frankfurt am Main, Germany) for 60 s. Following repeated rinsing with PBS, bone pieces were put in 
a tissue culture-treated petri dish covered with growth medium. JHOBs were expanded upon confluency around 
the bone pieces and used at passage 2. All consumables were obtained from Corning Inc. (Corning, USA) unless 
stated otherwise.
Irradiation. JHOBs were seeded according to the respective experimental section and allowed to attach 
to the culture dish overnight. The next day (= day 0), cells were treated with 2, 6, or 10  Gy X-ray radiation 
dose using the Y.MaxiShot X-ray unit (Yxlon, Hongkong, People’s Republic of China; settings: 200 kV, 10 mA, 
5.5 FOC). Non-irradiated cells were used as a control (“0 Gy”). Following the radiation procedure, a medium 
exchange was performed. Live imaging was performed throughout the cultivation period using the BIOREVO 
BZ-9000 microscope (Keyence, Osaka, Japan).
Proliferation. To investigate the impact of the radiation dose on the proliferation of JHOBs, cells were 
stained with CellTrace Violet (Invitrogen, Carlsbad, USA) following the manufacturer’s instructions. Cells 
were seeded in 12-well plates at 7500 cells  cm−2 in growth medium with and without the proliferation inhibitor 
deferoxamine (DFO)51. Irradiation of cultured cells was performed the following day (= day 0). Sampling was 
performed every day until day 7. For this, cells were trypsinized, washed with PBS + 5 mM ethylenediamine-
tetraacetic acid (EDTA; Corning) + 3% bovine serum albumin (Gibco) and analysed using the MACSQuant 
Analyzer (Miltenyi, Bergisch Gladbach, Germany) flow cytometer. Data were processed using FlowJo 10 (FlowJo 
LLC, Ashland, USA). Three wells were analysed per condition and sampling point (n = 3 biological replicates for 
each donor). Medium was exchanged every other day.
The decrease in fluorescence signal intensity correlates with the proliferative activity of the cells, as the dye 
is taken up by the cells, gets hydrolyzed and is divided evenly between the daughter cells upon cell division. To 
compensate for the decrease in fluorescence signal intensity (FI) due to other factors, e.g. photobleaching, cells 
were cultivated in growth medium supplemented with DFO at 100 µM (Sigma-Aldrich, Saint Louis, USA). Cells 
were gated for the main population in SSC/FSC and single cell inclusion. Gates for CellTrace Violet-positive 
cells were set using an unstained control at day − 1. Proliferation index of the cells was calculated as followed: 
1 − ((MFI−DFO, day x −  MFI+DFO, day x)/MFIday − 1) with MFI being the median FI of CellTrace-positive cells.
Mineralization. To analyze the mineralization capacity of JHOBs dependent on the radiation dose, cells were 
seeded at 10,000 cells  cm−2 in 12-well or 96-well plates, irradiated as described above and cultivated for 28 days in 
osteogenic medium (growth medium supplemented with 10 mM β-glycerophosphate (Sigma-Aldrich), 10 nM 
dexamethasone (AppliChem, Darmstadt, Germany) and 284 µM ascorbic acid phosphate (Sigma-Aldrich)). For 
every condition and sampling time, three wells were analysed (n = 3 biological replicates for each donor). Cells 
were fixated using 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, USA), washed with PBS and 
distilled water, and stained using 55 mM Alizarin Red S solution (pH 4.1) (C.I. 58005; Carl Roth, Karlsruhe, Ger-
many) for 10 min at room temperature. Stained samples were carefully washed with distilled water, and images 
were taken using the BIOREVO BZ-9000 microscope (Keyence). Extraction was executed by adding 10% w/v 
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cetylpyridinium chloride (CPC) (Sigma-Aldrich) and incubating for 1 h at room temperature. Absorption was 
measured at 550 nm and Alizarin Red S was quantified using a standard curve.
Immunofluorescence. To evaluate expression of marker proteins, an immunofluorescence staining was 
performed. JHOBs were seeded at 10,000 cells  cm−2 in 96-well plates and irradiated as described above. Follow-
ing this, cells were cultivated in osteogenic medium for 28 days. Monolayers were washed with PBS, fixated for 
5 min at room temperature using 4% paraformaldehyde and washed with PBS. Following permeabilization with 
0.3% Triton X-100 (Alfa Aesar, Ward Hill, USA) at room temperature for 10 min, samples were washed with PBS 
and blocked with 10% goat serum (Sigma-Aldrich) in PBS for 20 min at room temperature. Primary antibodies, 
diluted 1:100 in blocking buffer, were incubated at room temperature for 2 h (rabbit anti-RUNX2, mouse anti-
alkaline phosphatase, rabbit anti-osteopontin, rabbit anti-fibronectin, rabbit anti-osteonectin (Abcam, Cam-
bridge, United Kingdom); mouse anti-collagen I (Sigma-Aldrich); mouse anti-vimentin (Santa Cruz Biotechnol-
ogy, Dallas, USA)). For antibody controls, samples were incubated with blocking buffer only. After washing with 
PBS, samples were incubated with secondary antibodies (goat anti-mouse-CF488 and goat anti-rabbit-CF594 
(Biotium, Fremont, USA)), diluted 1:200 in blocking buffer, for 45 min at room temperature, while simultane-
ously counterstaining with 4′,6-diamidino-2-phenylindole (DAPI; Roche, Basel, Switzerland). After washing 
three times with PBS, images were taken using the BIOREVO BZ-9000 microscope (Keyence).
Real‑time PCR. To assess the relative expression of bone-specific marker genes on mRNA level, semi-quan-
titative real-time PCR was performed (see Table 1). For this, JHOBs were seeded at 10,000 cells  cm−2 in 6-well 
plates and irradiated the next day as described above (= day 0). Cells were switched to osteogenic medium fol-
lowing the irradiation. Total mRNA of JHOBs was isolated after 0, 7 and 28 days of cultivation using the Nucle-
oSpin RNA Mini or XS kit (MACHEREY-NAGEL, Düren, Germany) following the manufacturer’s protocols. 
For every condition and sampling time, three wells were analyzed (n = 3 biological replicates for each donor). 
mRNA was quantified using the NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific) and cDNA 
was synthesized using the TaqMan Reverse Transcription kit (Applied Biosystems, Foster City, USA) according 
to the manufacturer’s protocol. Real-time PCR was performed using the CFX96 real-time PCR system (Bio-
Rad, Munich, Germany). For this, cDNA equivalent to 5 ng total mRNA, 10 µM of the respective primers and 
SensiFAST SYBR No-ROX qPCR master mix (Bioline, Luckenwalde, Germany) were mixed in a total volume 
of 20 µL. After each PCR run, a melting curve analysis was performed to exclude non-specific amplification. 
Relative mRNA expression of marker genes was normalized to the house-keeping gene ubiquitin-conjugating 
enzyme E2 D2 (UBE2D2).
Statistical analysis. Statistical analyses were performed using GraphPad Prism 8 (San Diego, USA). All 
values are given as mean ± s.d. One-way ANOVA with Tukey’s multiple comparison test was performed to ana-
lyze the overall impact of irradiation on the proliferation between donors. To investigate the impact of irradia-
tion on proliferation for the combined data of all donors, two-way ANOVA with Tukey’s multiple comparison 
test was used. Brown-Forsythe ANOVA with Dunnett-T3 test was applied to analyze the proliferation data for 
significant changes between the irradiation conditions for each donor. For analysis of Real-time PCR data, two-
way ANOVA with Tukey’s multiple comparison test was used. P values smaller than or equal to 0.05 were con-
sidered significant.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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